Andover, MA, United States of America

Frances Fang


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Frances Fang – Innovator in Histone Methyltransferase Inhibitors

Introduction

Frances Fang is a distinguished inventor based in Andover, MA, recognized for her contributions to the field of biochemistry, particularly in the development of histone methyltransferase inhibitors. With three patents to her name, she focuses on innovative solutions that have the potential to significantly impact therapeutic approaches in cancer treatment.

Latest Patents

Frances has made notable advancements with her latest patents, which include the invention of a salt form of a human histone methyltransferase EZH2 inhibitor. The primary compound described in her patents is N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1′-biphenyl]-3-carboxamide hydrobromide. Additionally, her patents detail a particular polymorph form of this compound, showcasing her innovative approach to drug development.

Career Highlights

Throughout her career, Frances has collaborated with leading organizations in the pharmaceutical industry, including Eisai R&D Management Co., Ltd and Epizyme, Inc. Her work has significantly influenced research practices and has contributed to the advancement of methyltransferase inhibitors utilized in clinical settings.

Collaborations

Frances has had the opportunity to work alongside talented individuals such as Kevin Wayne Kuntz and Kuan-Chun Huang. These collaborations have enriched her research, allowing for the exchange of ideas and the pursuit of innovative solutions in the realm of biochemistry and drug development.

Conclusion

Frances Fang stands out as an exemplary inventor who is dedicated to advancing the field of histone methyltransferase inhibitors. Her innovative patents and professional collaborations highlight her commitment to improving therapeutic options for patients. As she continues her work, she undoubtedly inspires others in the scientific community to pursue their creative ideas and contribute to impactful innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…